These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15054688)

  • 21. Level of asymmetric dimethylarginine and carotid atherosclerosis in patients with chronic kidney disease.
    Zhang WR; Hou FF; Ning JP; Yang XB; Wu Q; Tao LJ; Chen BM; Li HY; Chang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):621-8. PubMed ID: 17062918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
    Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
    Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma asymmetric dimethylarginine (ADMA) is associated with retinopathy in type 2 diabetes.
    Malecki MT; Undas A; Cyganek K; Mirkiewicz-Sieradzka B; Wolkow P; Osmenda G; Walus-Miarka M; Guzik TJ; Sieradzki J
    Diabetes Care; 2007 Nov; 30(11):2899-901. PubMed ID: 17704346
    [No Abstract]   [Full Text] [Related]  

  • 24. Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
    Hov GG; Aasarød KI; Sagen E; Åsberg A
    Clin Biochem; 2015 Jul; 48(10-11):646-51. PubMed ID: 25828044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach.
    Ravani P; Tripepi G; Malberti F; Testa S; Mallamaci F; Zoccali C
    J Am Soc Nephrol; 2005 Aug; 16(8):2449-55. PubMed ID: 15944335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G
    Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress.
    Zhang WZ; Venardos K; Chin-Dusting J; Kaye DM
    Hypertension; 2006 Aug; 48(2):278-85. PubMed ID: 16801489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance, ADMA levels, and cardiovascular disease.
    Nash DT
    JAMA; 2002 Mar; 287(11):1451-2. PubMed ID: 11903034
    [No Abstract]   [Full Text] [Related]  

  • 30. Relations between concentrations of asymmetric dimethylarginine and neopterin as potential risk factors for cardiovascular diseases in haemodialysis-treated patients.
    Avci E; Coskun S; Cakir E; Kurt Y; Ozgur Akgul E; Bilgi C
    Ren Fail; 2008; 30(8):784-90. PubMed ID: 18791952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EPO induces rise in serum ADMA but does not prevent the increase in NO release: the likely involvement of HO-1.
    Calò LA; Davis PA
    Nephrol Dial Transplant; 2008 Sep; 23(9):3035-6; author reply 3036-7. PubMed ID: 18596127
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
    Nanayakkara PW; Teerlink T; Stehouwer CD; Allajar D; Spijkerman A; Schalkwijk C; ter Wee PM; van Guldener C
    Kidney Int; 2005 Nov; 68(5):2230-6. PubMed ID: 16221223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients.
    Mittermayer F; Schaller G; Pleiner J; Vychytil A; Sunder-Plassmann G; Hörl WH; Wolzt M
    J Am Soc Nephrol; 2005 Jun; 16(6):1832-8. PubMed ID: 15857920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study.
    Juonala M; Viikari JS; Alfthan G; Marniemi J; Kähönen M; Taittonen L; Laitinen T; Raitakari OT
    Circulation; 2007 Sep; 116(12):1367-73. PubMed ID: 17724260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease.
    Wang J; Sim AS; Wang XL; Salonikas C; Naidoo D; Wilcken DE
    Atherosclerosis; 2006 Feb; 184(2):383-8. PubMed ID: 15939423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular mechanisms of dysfunction of vascular endothelium].
    Markov KhM
    Kardiologiia; 2005; 45(12):62-72. PubMed ID: 16353051
    [No Abstract]   [Full Text] [Related]  

  • 37. Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein G; Busch M; Müller A; Wendt T; Franke C; Niwa T; Franke S
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S52-6. PubMed ID: 12612953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
    Xiong Y; Lei M; Fu S; Fu Y
    Life Sci; 2005 May; 77(2):149-59. PubMed ID: 15862600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease.
    Bode-Böger SM; Scalera F; Kielstein JT; Martens-Lobenhoffer J; Breithardt G; Fobker M; Reinecke H
    J Am Soc Nephrol; 2006 Apr; 17(4):1128-34. PubMed ID: 16481412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular events in chronic advanced renal insufficiency. Current concepts].
    Zoccali C
    Recenti Prog Med; 2003 Mar; 94(3):125-30. PubMed ID: 12677780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.